World's Best Scientists 2026 revealed!
Fernando C. Fervenza

Fernando C. Fervenza

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 103 7292 6850 3818 3533 489 44293

Fernando C. Fervenza publications per year

The chart shows the history of publications by Fernando C. Fervenza between 1989 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Fernando C. Fervenza published across 37 years, from 1989 to 2025, averaging 14.9 papers a year. Output peaked at 46 publications in 2021. 72 of the 552 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1989 to 2025. Vertical axis: number of publications, 0 to 46. Peak 46 publications in 2021. 1989: 2 publications 1990: 1 publication 1991: 2 publications 1992: 0 publications 1993: 0 publications 1994: 1 publication 1995: 1 publication 1996: 3 publications 1997: 3 publications 1998: 3 publications 1999: 3 publications 2000: 3 publications 2001: 5 publications 2002: 2 publications 2003: 1 publication 2004: 7 publications 2005: 5 publications 2006: 5 publications 2007: 3 publications 2008: 16 publications 2009: 17 publications 2010: 14 publications 2011: 28 publications 2012: 23 publications 2013: 16 publications 2014: 21 publications 2015: 22 publications 2016: 33 publications 2017: 24 publications 2018: 30 publications 2019: 33 publications 2020: 30 publications 2021: 46 publications 2022: 35 publications 2023: 42 publications 2024: 38 publications 2025: 34 publications
1989 2025

552 publications in total across all disciplines

View publications per year as a table
Fernando C. Fervenza: publications per year, 1989 to 2025
Year Publications
1989 2
1990 1
1991 2
1992 0
1993 0
1994 1
1995 1
1996 3
1997 3
1998 3
1999 3
2000 3
2001 5
2002 2
2003 1
2004 7
2005 5
2006 5
2007 3
2008 16
2009 17
2010 14
2011 28
2012 23
2013 16
2014 21
2015 22
2016 33
2017 24
2018 30
2019 33
2020 30
2021 46
2022 35
2023 42
2024 38
2025 34
Total 552
Download as CSV

Fernando C. Fervenza publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Fernando C. Fervenza sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 481–500 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 489 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713 489
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Fernando C. Fervenza D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Fernando C. Fervenza sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 102–103 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630 103
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Fernando C. Fervenza is a researcher affiliated with the Mayo Clinic in the United States, specializing in the field of medicine, with a primary focus on nephrology. Their scholarly contributions are mainly concentrated in renal diseases and glomerulopathies, vasculitis and related conditions, as well as chronic kidney disease and diabetes. Other significant topics addressed in their work include coagulation, bradykinin, polyphosphates, and angioedema, amyloidosis diagnosis and treatment, complement system in diseases, and autoimmune bullous skin diseases.

Fervenza has authored numerous publications, notably appearing in prominent nephrology and renal medicine journals. Frequent publication venues include:

  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • Kidney International
  • Nephrology Dialysis Transplantation
  • Clinical Journal of the American Society of Nephrology

Their recent notable papers include:

  • KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases, 2021, Kidney International
  • Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases, 2021, Kidney International
  • Membranous nephropathy, 2021, Nature Reviews Disease Primers
  • The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis, 2020, Nature Communications
  • Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients, 2020, Kidney International

Fernando C. Fervenza collaborates frequently with several researchers, reflecting a diverse network of academic partnerships. Their frequent co-authors include:

  • Sanjeev Sethi
  • Ladan Zand
  • Ulrich Specks
  • Samih H. Nasr
  • Marta Casal Moura

Their research spans multiple subfields such as pulmonary and respiratory medicine, genetics, molecular biology, and pathology and forensic medicine, contributing broadly to interdisciplinary medical sciences. This multidisciplinary approach complements their primary focus on nephrology and related renal pathologies.

Best Publications

  • Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

    John H. Stone;Peter A. Merkel;Robert Spiera;Philip Seo

  • Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study†

    Brad H. Rovin;Richard Furie;Kevin Latinis;R. John Looney

  • KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

    Brad H. Rovin;Sharon G. Adler;Jonathan Barratt;Frank Bridoux

  • The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification

    Daniel C. Cattran;Rosanna Coppo;H. Terence Cook;John Feehally

  • The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

    Ian S.D. Roberts;H. Terence Cook;Stéphan Troyanov;Charles E. Alpers

  • Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

    Daniel C. Cattran;John Feehally;H. Terence Cook;Zhi Hong Liu

  • Efficacy of Remission-Induction Regimens for ANCA-associated Vasculitis

    Ulrich Specks;Peter A. Merkel;Philip Seo;Robert Spiera

  • Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

  • C3 glomerulopathy: consensus report

    Matthew C. Pickering;Vivette D. D'agati;Carla M. Nester;Richard J. Smith

  • Membranoproliferative Glomerulonephritis — A New Look at an Old Entity

    Sanjeev Sethi;Fernando C. Fervenza

  • Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.

    Laurence H. Beck;Fernando Custodio Fervenza;David M. Beck;Ramon G B Bonegio

  • Rituximab for Refractory Wegener's Granulomatosis: Report of a Prospective, Open-Label Pilot Trial

    Karina A. Keogh;Steven R. Ytterberg;Fernando C. Fervenza;Kimberly A. Carlson

  • Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.

    Brad H. Rovin;Sharon G. Adler;Jonathan Barratt;Frank Bridoux

  • The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

    Nelson Leung;Frank Bridoux;Vecihi Batuman;Aristeidis Chaidos

  • Diagnosis of monoclonal gammopathy of renal significance

    Frank Bridoux;Nelson Leung;Colin A. Hutchison;Guy Touchard

  • Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

    Fernando C. Fervenza;Gerald B. Appel;Sean J. Barbour;Brad H. Rovin

  • Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

    Ulrich Specks;Fernando C. Fervenza;Thomas J. McDonald;Marie C. E. Hogan

  • C3 glomerulonephritis: Clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up

    Sanjeev Sethi;Fernando C. Fervenza;Yuzhou Zhang;Ladan Zand

  • The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society:

    Daniel C. Cattran;Rosanna Coppo;H. Terence Cook;John Feehally

  • ATYPICAL HEMOLYTIC UREMIC SYNDROME AND C3 GLOMERULOPATHY: CONCLUSIONS FROM A «KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES» (KDIGO) CONTROVERSIES CONFERENCE

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

Frequent Co-Authors

Sanjeev Sethi
Sanjeev Sethi Mayo Clinic
Nelson Leung
Nelson Leung Mayo Clinic
Ulrich Specks
Ulrich Specks Mayo Clinic
Samih H. Nasr
Samih H. Nasr Mayo Clinic
John H. Stone
John H. Stone Harvard University
Richard J.H. Smith
Richard J.H. Smith University of Iowa
Daniel C. Cattran
Daniel C. Cattran University Health Network
E. William St. Clair
E. William St. Clair Duke University
Gary S. Hoffman
Gary S. Hoffman Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up a wide range of related online degree options and alternative pathways. For those interested in nursing but concerned about exam requirements, there are nursing schools that don't require teas test, making entry more accessible for some prospective students.

If leadership and management in healthcare appeal to you, consider enrolling in an accelerated healthcare administration degree online. These programs are designed for those who wish to quickly advance into administrative or managerial roles within healthcare systems.

For licensed nurses aiming to become nurse practitioners, ASN holders can explore tailored bridge programs, such as an asn to np degree pathway. This route helps streamline the process of earning an MSN and expanding clinical capabilities.

Nutrition and food science are also promising fields, especially with flexible learning options. Discover the best online food science degree programs to find opportunities in research, public health, or the food industry.

Best Scientists Citing Fernando C. Fervenza

Trending Scientists

Recently Published Articles